It follows the release of the Wegovy pill by Novo Nordisk in December, according to CNBC
Wegovy is approved for weight loss and heart disease treatment in adults who are obese or overweight with known heart conditions
Individual response varies : Some women may see faster results
Strehlow K, Rotter S, Wassmann S, Adam O, Groh C, Laufs K, et al
Many women also begin developing some level of insulin resistance or metabolic dysfunction during this phase of life, which makes weight management feel dramatically harder than it did in earlier decades
Notably, Ozempics advertisements have captivated audiences worldwide, highlighting its potential for weight loss